Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.
NCT00380302
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
162
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
AVE1625
Sponsor
Sanofi